Trial Outcomes & Findings for A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma (NCT NCT00461812)
NCT ID: NCT00461812
Last Updated: 2017-09-20
Results Overview
TERMINATED
PHASE4
33 participants
change from baseline to study completion
2017-09-20
Participant Flow
33 participants were consented for this study. However, there were 23 pre-randomization screening failures. Only 10 were enrolled. The number of participants assigned/randomized to each Arm/Group is unknown.
Participant milestones
| Measure |
All Participants
Mometasone
or
Advair
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
10
|
Reasons for withdrawal
| Measure |
All Participants
Mometasone
or
Advair
|
|---|---|
|
Overall Study
study terminated
|
10
|
Baseline Characteristics
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Baseline characteristics by cohort
| Measure |
All Participants
n=10 Participants
Mometasone
or
Advair
|
|---|---|
|
Age, Customized
>=18, <=16 years
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: change from baseline to study completionPopulation: There is no data available for this outcome measure. The study was prematurely terminated and the PI is no longer with the institution. The information available was obtained from the IRB.
Outcome measures
Outcome data not reported
Adverse Events
All Participants
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Johns Hopkins University Clinical Trials Program
Johns Hopkins University School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place